WNT5A and neoplasm: Compared to correlation with poor prognosis in gastric cancer and melanomas [32], Wnt5a was discovered as an antagonist to the canonical Wnt signaling pathway with tumor suppressor activity in differentiated thyroid carcinomas [20].